Yoshio Matsumi
Director/Board Member bij JTEC CORPORATION
Profiel
Yoshio Matsumi is an Independent Non-Executive Outside Director at JTEC Corp.
and the Representative Director of Matsumi Associates GK.
He was the President & Chief Executive Officer of Novartis Pharma KK from 1999 to 2004.
He was also the Vice Chairman of Novartis Pharma AG, Director of Johnson Co., Ltd., and Director of Solasia Pharma KK.
Matsumi worked at ITOCHU Corp.
for 38 years, where he was a Principal and Managing Executive Officer.
He was also the President of Monsanto Japan Ltd.
and Principal of Bristol-Myers Squibb KK.
Matsumi was the President of OSAKA University Venture Capital Co., Ltd.
from 2014 to 2019.
He received his undergraduate degrees from Osaka University and Osaka University of Foreign Studies in 1969.
Currently, he holds the position of Independent Non-Executive Outside Director at JTEC Corp.
and Representative Director of Matsumi Associates GK.
Actieve functies van Yoshio Matsumi
| Bedrijven | Functie | Begin |
|---|---|---|
| JTEC CORPORATION | Director/Board Member | 01-09-2018 |
| Matsumi Associates GK | Director/Board Member | 01-04-2009 |
Eerdere bekende functies van Yoshio Matsumi
| Bedrijven | Functie | Einde |
|---|---|---|
OSAKA University Venture Capital Co., Ltd.
 OSAKA University Venture Capital Co., Ltd. Investment ManagersFinance OSAKA University Venture Capital Co., Ltd. (OUVC) is a Venture Capital firm, a subsidiary of Osaka University founded in 2014. OSAKA University Venture Capital Co., Ltd. is headquartered in Suita. | President | 11-12-2019 |
| ITOCHU CORPORATION | Corporate Officer/Principal | 01-07-2007 |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | President | 01-01-2004 |
Monsanto Japan Ltd.
 Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The private company is based in Tokyo, Japan. | President | - |
| ITOCHU CORPORATION | Corporate Officer/Principal | - |
Opleiding van Yoshio Matsumi
| Osaka University | Undergraduate Degree |
| Osaka University of Foreign Studies | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ITOCHU CORPORATION | Distribution Services |
| SOLASIA PHARMA K.K. | Health Technology |
| JTEC CORPORATION | Electronic Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Johnson Co., Ltd.
 Johnson Co., Ltd. Household/Personal CareConsumer Non-Durables Johnson Co., Ltd. engages in the manufacture and sale of household cleaners, insecticides, and disinfectants. It also offers shoe care products, air freshener, and oil waste treatment agents. The company was founded on July 1, 1962 and is headquartered in Yokohama, Japan. | Consumer Non-Durables |
Monsanto Japan Ltd.
Monsanto Japan Ltd. Chemicals: AgriculturalProcess Industries Part of Bayer AG, Monsanto Japan Ltd. is a Japanese company that manufactures a wide range of genetically altered seeds, fertilizers, and agrochemicals. The private company is based in Tokyo, Japan. | Process Industries |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Health Technology |
Bristol-Myers Squibb KK
 Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The private company is based in Shinjuku-ku, Japan. | Health Technology |
OSAKA University Venture Capital Co., Ltd.
OSAKA University Venture Capital Co., Ltd. Investment ManagersFinance OSAKA University Venture Capital Co., Ltd. (OUVC) is a Venture Capital firm, a subsidiary of Osaka University founded in 2014. OSAKA University Venture Capital Co., Ltd. is headquartered in Suita. | Finance |
| Matsumi Associates GK |
